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Acute Lead Dislodgements and
In-Hospital Mortality in Patients Enrolled in
the National Cardiovascular Data Registry
Implantable Cardioverter Defibrillator Registry
Alan Cheng, MD,* Yongfei Wang, MS,† Jeptha P. Curtis, MD,† Paul D. Varosy, MD‡
Baltimore, Maryland; New Haven, Connecticut; and Aurora, Colorado
Objectives We sought to describe the incidence of acute lead dislodgements and the consequences of these events in patients
enrolled in the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter-Defibrillator (ICD) Registry.
Background Lead dislodgements are common adverse events in patients undergoing ICD implants. Little is known regarding
who is at risk and the consequences of these events.
Methods Patients enrolled between April 2006 and September 2008 were included. Acute lead dislodgement was de-
fined as movement of the lead requiring another procedure for repositioning before discharge.
Results Acute dislodgement occurred in 2,628 of 226,764 patients. Univariate variables associated with dislodgements
included older age, female sex, and patients with atrial fibrillation, chronic lung disease, cerebrovascular dis-
ease, nonischemic cardiomyopathy, and lower ejection fractions (all p  0.002). After multivariate adjustment,
factors associated with an increased risk for dislodgement included New York Heart Association functional class
IV heart failure, atrial fibrillation/flutter, having a cardiac resynchronization therapy-defibrillator device, and pro-
cedures performed by physicians trained under alternative pathways. A teaching/training hospital setting was
not a factor (p  0.64). Acute dislodgements had increased odds for other adverse events including cardiac ar-
rest, cardiac tamponade, device infection, pneumothorax, and in-hospital death even after adjustment for poten-
tial confounders (all p  0.0001).
Conclusions Acute lead dislodgements occur more often in patients with more comorbidities and in patients undergoing im-
plants by nonelectrophysiology-trained implanters. These events were strongly associated with increased odds
for in-hospital death. (J Am Coll Cardiol 2010;56:1651–6) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.037W
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tead dislodgements are common complications (1,2), often
esulting in prolonged hospital stays and increased costs (3).
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ccepted June 6, 2010.hile the frequency of long-term lead dislodgements
anges between 1.8% and 8% (4–8), little is known about
he frequency of acute lead dislodgements and risk factors
ssociated with these events. Utilizing the National Cardio-
ascular Data Registry (NCDR) Implantable Cardioverter-
efibrillator (ICD) Registry, we sought to determine the
revalence of acute lead dislodgements, factors associated
ith these complications, and the prevalence of other more
erious adverse events caused by or closely associated with
hem.
ethods
ata source and study cohort. Analyses used data from
he NCDR ICD Registry. All procedures performed be-
ween April 2006 and September 2008 were screened;
atients with prior ICDs were excluded.
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Lead Dislodgements and In-Hospital Death November 9, 2010:1651–6Outcomes. The occurrence of
an acute lead dislodgement was
the primary end point, and the
occurrence of other adverse
events caused by or closely asso-
ciated with the dislodgement was
the secondary end point. Acute
dislodgements were defined as
those involving movement of the
lead requiring another procedure
for repositioning before patient
discharge. To account for poten-
tial variations in data coding, pa-
tients who experienced cardiac
perforations were also included
s having experienced an acute lead dislodgement. Other
dverse events included cardiac arrest, drug reaction, coro-
ary venous dissection, hematoma, pneumothorax, periph-
ral embolus, superficial phlebitis, myocardial infarction,
ericardial tamponade, infection related to device, and
n-hospital death.
ndependent confounders. Confounding variables consid-
red included admission characteristics, patient comorbidi-
ies, and physician/hospital characteristics. The rate of
issing data was extremely low for all variables (0.5%)
ith the exception of ejection fraction (1.5%). To avoid
ase-wise deletion, missing values were imputed. For cate-
orical variables, the missing variables were imputed with
he most common value present in the cohort. For contin-
ous variables, the missing values were imputed as the
edian among those with the data present. In cases of
issing data, dummy variables were constructed to indicate
here the variable was missing. In multivariable models,
oth imputed values and dummy variables were included.
tatistical methods. Baseline demographic and clinical fac-
ors were compared between patients with acute dislodgements
nd patients without using chi-square testing and t tests as
ppropriate. Independent associations of various characteristics
ere identified using a hierarchical logistic regression model to
ccount for clustering of patients within hospitals and regional
ifferences in demographics. Variables selected for the multi-
ariate analyses were chosen based on the plausibility that they
ould be associated with the end point. The analyses were then
epeated for subjects undergoing cardiac resynchronization
herapy-defibrillator (CRT-D) implantation. Finally, associa-
ions of acute dislodgements with other adverse events were
dentified. Significant variables were those with a p 0.05. All
nalyses were approved by the Yale Human Investigation
ommittee and performed using the SAS Statistical Package
ersion 9.1 (SAS Institute, Cary, North Carolina).
esults
aseline demographics and characteristics associated with
ead dislodgements. During the period studied, 296,534
Abbreviations
and Acronyms
CRT-D  cardiac
resynchronization
therapy-defibrillator
EP  electrophysiology
ICD  implantable
cardioverter-defibrillator
LV  left ventricular
NCDR  National
Cardiovascular Data
Registry
NYHA  New York Heart
Associationmplants were recorded in the ICD Registry. After exclud-
g
Ang patients with previous ICDs, 226,764 remained. Among
26,764 entries, 79,909 (35.2%) underwent CRT-D im-
lantation. Baseline demographics of the entire cohort are
llustrated in Table 1. Acute dislodgement was the most
ommon adverse event reported, and occurred in 2,628
1.2%) patients. For the 3 types of device systems, namely,
ingle-chamber, dual-chamber, and CRT-D, the rates were
.56%, 0.97%, and 1.78%, respectively. Unadjusted variables
ssociated with acute dislodgements included older age,
emale sex, more advanced heart failure, and a greater
umber of comorbidities (Table 2). Patients who had
re-existing pacemaker leads or those undergoing CRT-D
evices were also more likely to have experienced an acute
islodgement. In fact, 54.3% of dislodgements were in
atients who had undergone CRT-D implants.
Among physician and hospital characteristics, several
actors were associated with acute dislodgements and in-
luded physician’s experience (as defined by volume) and
raining (Table 3). When physician implant volumes were
roken down by quartiles (Fig. 1) and stratified by type of
evice implanted, acute dislodgement rates were lower for
hose with higher volumes, as previously reported (10),
aseline Patient Demographicsor the Entire Cohort AnalyzedTable 1 Baseline Patient Demographicsfor the Entire Cohort Analyzed
Age, yrs 67.5 13.0
Female 27.0%
Race
White 78.8%
Black 12.8%
Hispanic 5.4%
Other 3.1%
NYHA functional class
I 12.3%
II 35.7%
III 47.6%
IV 4.4%
Atrial fibrillation/flutter 31.3%
Cardiac transplantation 0.2%
Nonischemic cardiomyopathy 32.1%
Prior coronary bypass 34.0%
Prior pacemaker implanted 11.2%
History of CVA 14.5%
Chronic lung disease 22.8%
Diabetes mellitus 37.2%
Hypertension 75.2%
GFR 60 ml/min 58.7%
Hemodialysis 4.2%
Left ventricular ejection fraction, % 27.5 10.7
QRS duration, ms 125.4 34.3
Left bundle branch block 26.0%
Single-chamber ICD 24.0%
Dual-chamber ICD 40.6%
CRT-D 35.2%
ategorical data reported as percentages. Continuous data reported are mean  SD.
CRT-D cardiac resynchronization therapy-defibrillator; CVA cerebrovascular accident; GFR
lomerular filtration rate; ICD  implantable cardioverter defibrillator; NYHA  New York Heart
ssociation.
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November 9, 2010:1651–6 Lead Dislodgements and In-Hospital Deathxcept in the case of single-chamber devices (single-
hamber, p 0.30; dual-chamber, p 0.005; CRT-D, p
.002). In terms of physician training, board certification
nd board eligibility in electrophysiology (EP) were the only
factors associated with a lower likelihood of acute dis-
odgements. Fulfilling criteria established as an alternative
raining pathway (11) was not associated with fewer dis-
odgements. Although hospital size (i.e., bed number) had
o significant effect, there appeared to be more lead dis-
odgements occurring in community-based institutions. The
eaching status of the hospital (where trainees may be
nvolved in these procedures) was not associated with
ncreased risk for dislodgement.
Multivariate models were generated with variables that
ould plausibly be associated with acute dislodgements.
his demonstrated increased odds for acute dislodgements
or females, for patients who had NYHA functional class IV
eart failure, atrial fibrillation/flutter, and for patients who
ad received dual and CRT-D devices (Table 4). Patients
ith a history of coronary artery bypass graft surgery had
Unadjusted Demographic CharacteristicsAmong Patients With and Without Acute Lead DTable 2 Unadjusted Demograph CharacterAmong Patients With and Without A
Variable Acute Dislodgemen
Age, yrs 68.6 12.7
Female 31.9%
Race
White 81.5%
Black 11.5%
Hispanic 3.8%
Other 3.2%
NYHA functional class
I 9.0%
II 26.4%
III 58.4%
IV 6.2%
Atrial fibrillation 35.3%
Cardiac transplantation 0.2%
Ischemic cardiomyopathy 61.8%
Prior pacemaker 14.0%
CVA 16.5%
Lung disease 25.8%
Diabetes mellitus 37.7%
Hypertension 74.2%
GFR 60 ml/min 57.8%
Ejection fraction, % 26.8 10.4
QRS duration, ms 134.8 35.0
Left bundle branch block 35.0%
ICD type
Single-chamber 11.6%
Dual-chamber 34.0%
CRT-D 54.3%
LV lead implanted
Coronary sinus 49.2%
Noncoronary sinus 4.1%
Categorical data reported as percentages. Continuous data reported a
LV  left ventricular; other abbreviations as in Table 1.ecreased odds for dislodgements. Whereas hospital volume aad no effect on the odds for dislodgement, physician
raining did. When compared with physicians who were
oard certified or eligible in EP, physicians who had
ompleted an alternative training pathway (11) were the
nly ones with increased odds for dislodgement.
cute lead dislodgements in patients undergoing CRT-D
mplantation. Among 79,909 patients who underwent
RT-D implantation, data on the type of LV lead used was
vailable for 99.6%. Coronary sinus leads were implanted
4.8% of the time, with noncoronary sinus leads represent-
ng 3.9%. Acute dislodgements occurred with a frequency of
.8%. Factors associated with lead dislodgements included
emale sex, having nonischemic cardiomyopathy, and re-
eiving a noncoronary sinus LV lead. Higher physician
mplant volumes were associated with fewer dislodgements.
lectrophysiology board certification/eligibility was not a
actor in this subset despite being a factor in the entire
ohort. Hospital characteristics were also not significantly
ssociated with acute dislodgements. When these variables
ere applied in a multivariate model, the only factor
gements
Lead Dislodgements
No Acute Dislodgement p Value
67.5 13.0 0.0001
27.0% 0.0001
0.005
78.7%
12.8%
5.4%
3.1%
0.0001
12.4%
35.8%
47.4%
4.4%
31.3% 0.0001
0.2% 0.4755
68.0% 0.0001
11.2% 0.0001
14.5% 0.0035
22.8% 0.0002
37.1% 0.5282
75.2% 0.2321
58.7% 0.3349
27.5 10.7 0.0017
125.3 34.3 0.0001
25.9% 0.0001
0.0001
24.2%
40.6%
35.0%
0.0001
33.2%
1.3%
n  SD.islodistics
cute
tssociated with dislodgement was the type of LV lead
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Lead Dislodgements and In-Hospital Death November 9, 2010:1651–6mplanted. Patients receiving a noncoronary sinus lead had
ncreased odds (odds ratio: 2.00, confidence interval: 1.65 to
.41) for dislodgement when compared with patients re-
eiving a coronary sinus lead. As with the entire cohort,
rior coronary artery bypass grafting had decreased odds for
islodgement (odds ratio: 0.79, 95% confidence interval:
.71 to 0.87).
equelae of acute lead dislodgements on length of stay
nd other adverse events. The average length of stay in the
ntire cohort was 4.7 days. Patients who had an acute
islodgement had an increased length of stay by 2.3 days.
lthough a majority of acute dislodgements were isolated
vents, 10.9% were associated with other adverse events.
able 5 highlights both the minor and major events
etween patients with and without lead dislodgements.
inor events, including drug reactions, hematoma, and
uperficial phlebitis, were seen at a greater frequency among
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Physician Implant Volumes by Quartiles
p<0.004
Figure 1 Acute Lead Dislodgements
and Physician Implant Volume
Physician implant volumes were divided into quartiles (Q). Q1 represents physi-
cians with the lowest volume, and Q4 represents those with the highest
nadjusted Physician and Hospitalh racteristics Among Those Withd Without Acute Le d Dislodgements
Table 3
Unadjusted P y ician and Hospital
Characteristics Among Those With
and Without Acute Lead Dislodgements
Variable
Acute
Dislodgements
No Acute
Dislodgments p Value
Hospital type 0.027
Government 1.7% 1.5%
Private/community 86.6% 85.1%
University 11.6% 13.4%
Teaching hospital 55.2% 54.7% 0.638
Physician implant volume 135 96 144 101 0.0001
Physician training 0.011
Board-certified EP 75.4% 76.3%
Board-eligible EP 5.4% 6.0%
HRS guidelines 11.2% 9.7%
Surgery boards 2.6% 2.0%
ategorical data reported as percentages. Continuous data reported are mean  SD. Physician
mplant volume reflects average number of cases reported to the ICD Registry by implanters over
he time period studied. Board-eligible electrophysiology (EP) physicians are physicians who have
ompleted a formal cardiac EP training program but before passing the American Board of Internal
edicine certification examination in cardiac EP. Heart Rhythm Society (HRS) guidelines represent the
lternative training pathway discussed in text (11).atients with dislodged leads than among patients without
islodged leads. Major complications also occurred with
reater frequency among patients with lead dislodgements.
hese events included cardiac arrest, tamponade, pneumo-
horax, and device infection. After adjusting for various
actors, patients with acute dislodgements had significantly
reater odds for the combined major complications listed in
he preceding text. More importantly, there were also
reater odds for in-hospital death as a result of lead
islodgements (Table 6).
iscussion
atient characteristics associated with dislodgements.
cute dislodgement was the most common adverse event
eported and occurred 1.2% of the time. Despite a number
f unadjusted variables, only worse heart failure status and
he presence of atrial fibrillation/flutter were independently
djusted Odds Ratios for Acute Leadislodgement Among Various Clinical CharacteristicsTable 4 Adjusted Odds Ra ios for Acute LeadDislodgements Among Various Clinical Characteristics
Variable Odds Ratio 95% Confidence Interval
Age 1.01 0.99–1.02
Female 1.16 1.07–1.25
NYHA functional class II 0.99 0.86–1.14
NYHA functional class III 1.14 0.99–1.31
NYHA functional class IV 1.23 1.01–1.50
Atrial fibrillation/flutter 1.09 1.01–1.18
Nonischemic cardiomyopathy 1.10 1.01–1.19
Prior coronary artery bypass 0.82 0.75–0.90
Prior pacemaker 0.96 0.87–1.07
Chronic lung disease 1.10 1.01–1.19
Dual-chamber ICD 1.70 1.50–1.92
CRT-D 2.92 2.57–3.32
HRS guidelines 1.23 1.07–1.42
Surgery boards 1.22 0.95–1.56
Pediatric cardiology boards 0.93 0.77–1.12
eart Rhythm Society (HRS) guidelines refers to the alternative training pathway noted in text and
stablished by the HRS clinical competency statement on implantable cardioverter defibrillator
ICD) implantation (11). NYHA functional classes, device types (dual-chamber, CRT), and physician
ertifications referenced to NYHA functional class I, single-chamber ICD, and EP board certified/
ligible physicians, respectively.
Abbreviations as in Table 1.
utcomes and Complicationsssociated With Acute Lead DislodgementsTable 5 Outco es nd ComplicationsAssociated With Acute Lead Dislodgements
Variable
Acute
Dislodgements
No Acute
Dislodgements p Value
Length of stay 6.9 days 4.6 days 0.0001
Drug reaction 0.34% 0.09% 0.0001
Phlebitis, superficial 0.15% 0.04% 0.006
Hematoma 4.15% 0.97% 0.0001
Infection 0.23% 0.02% 0.0001
Peripheral embolus 0.19% 0.03% 0.0001
Cardiac arrest 1.45% 0.31% 0.0001
Cardiac perforation 7.04% 0.00% 0.0001
Pneumothorax 1.56% 0.47% 0.0001
Hemothorax 0.42% 0.09% 0.0001volume. In-hospital death 1.29% 0.41% 0.0001
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November 9, 2010:1651–6 Lead Dislodgements and In-Hospital Deathssociated with acute dislodgements. One could hypothesize
hat both of these factors contributed to more dislodged
eads, perhaps because of worsening myocardial architecture
nd chamber size, thus compromising lead stability. A few
otable “lack of associations” were also seen, including
hronic lung disease (i.e., pulmonary hypertension and
esultant significant tricuspid regurgitation) and a history of
oronary artery bypass (i.e., lack of a right atrial appendage
ompromising stable atrial lead placement). Interestingly,
atients who had undergone coronary bypass had a de-
reased risk for dislodgement. That could have been the
esult of surgically induced pericardial fibrosis that reduced
he risk of lead perforation.
hysician training, device characteristics, and outcomes
ssociated with dislodgements. Patients in the entire co-
ort who underwent implantation by physicians who had
ompleted an EP fellowship had fewer dislodged leads.
hen compared with these physicians, those trained under
lternative training pathways (11) were independently asso-
iated with more dislodgements. This finding did not
ppear to be simply a function of physician volume as the
verage number of implants per physician was 57.6 cases per
ear. What this more likely represents are inherent
ifferences in the way the training is performed. Being
rained in a formalized fellowship program where there
re clear hierarchical structures of authority may encour-
ge a freer exchange of constructive criticism, as com-
ared with being trained where training is occurring
etween contemporary colleagues. With regard to hospi-
al settings, teaching hospitals (where trainees with
imited experience are involved) were not associated with
higher incidence of dislodgements.
Although the ICD registry did not record the type/
ocation of implant of the dislodged lead, data on the type of
ystem implanted demonstrated a graded increase in the risk
or dislodgement for dual and CRT-D devices when com-
ared with single-chamber devices. In fact, 54% of dis-
odgements occurred in CRT-D devices. One could hy-
othesize this occurring because of the LV lead; however,
his may simply be a function of having more leads im-
lanted and thus having more at risk for dislodgement.
Perhaps the most important finding from this analysis is
he observation that 10.9% of acute dislodgements were
djusted Odds Ratios of the Effect of Acuteead Dislo gements on Development ofore Seri us Adver e Events and In-Hospital Death
Table 6
Adjus ed Odds Ratios f the Effect of Acute
Lead Dislodgements on the Development of
More Serious Adverse Events and In-Hospital Death
End Point
Odds
Ratio
95% Confidence
Interval p Value
Combined events (cardiac arrest,
tamponade, pneumothorax,
infection)
5.62 4.79–6.60 0.00001
In-hospital death 2.66 1.98–3.57 0.00001
djusted for age, sex, race, congestive heart failure, atrial fibrillation, cardiomyopathy etiology,
istory of cerebrovascular accident, lung disease, renal failure, ejection fraction, QRS duration,
hysician implant volume, and hospital volume.ssociated with other adverse events. Many of these wereinor, but major complications also occurred and resulted
n cardiac tamponade, cardiac arrest, pneumothorax, and
n-hospital death.
tudy limitations. First, because of data coding issues, we
ncorporated cardiac perforation as a form of dislodgement.
ome may argue that this is a separate entity. When we
nalyzed the cases excluding perforations, the findings did
ot change our conclusions. Second, acute dislodgements
ot resulting in reoperation or occurring after discharge
ere not included. Prior reports, however, suggest a major-
ty of lead dislodgements tend to occur within 72 h from
mplant (2,12). This time period would have been covered
n this analysis, as the average length of stay was 4 days.
hird, this was a cross-sectional study and outcomes in-
luding other adverse events and death may have occurred
fter discharge (13). However, our analysis is arguably more
pecific and focused on the relationship of acute dislodge-
ents with these other outcomes. Death occurring after
ischarge may have been secondary to other causes, and thus
ould be less specific in terms of its relationship to this
omplication. Fourth, we do not have information regarding
he type/implant location of the lead that dislodged. That is
articularly important in light of the counterintuitive obser-
ation that noncoronary sinus CRT-D systems had a higher
isk for dislodgement when compared with coronary sinus
ystems. It may be that additional manipulation of the
evice system increased the risk of other leads to dislodge,
ather than concluding that the noncoronary sinus lead was
ore unstable. Lastly, no data were collected on other
actors such as implant techniques, patient’s body habitus,
rocedural times, and post-operative management (i.e., arm
ling use, limitations in arm movement).
onclusions
cute lead dislodgement was the most common adverse
vent reported. Physician training was important in deter-
ining its outcome, and our findings call into question the
bility of alternative training pathways in achieving a com-
arable degree of expertise as compared with more formal-
zed methods. Heightened awareness for other adverse
vents should be made in the presence of acute dislodge-
ents given that 10.9% of cases were also associated with
nother type of complication, including in-hospital death.
eprint requests and correspondence: Dr. Alan Cheng, Johns
opkins University School of Medicine, 600 North Wolfe Street,
arnegie 568, Baltimore, Maryland 21287. E-mail: alcheng@
hmi.edu.
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